| Serial Number | 90058887 |
| Word Mark | RISURJJA |
| Filing Date | Friday, July 17, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, September 5, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 8, 2021 |
| Goods and Services | Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Biological and chemical preparations for the treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical reagents; Medical diagnostic reagents, assays, and test kits for testing of body fluids; cells, protein molecules, and molecular compounds in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely cancer, for medical use |
| Goods and Services | Medical services; medical testing services; DNA screening and analysis services for medical purposes |
| Goods and Services | Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of blood diseases, bone and bone marrow diseases, and cancers; scientific research and development; scientific laboratory services; medical laboratory services; conducting clinical trials for others; conducting clinical trial for others regarding pharmaceutical preparations and drugs in the field of blood diseases, bone and bone marrow diseases, and cancers; DNA screening and analysis services for scientific research purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 14, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 14, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 14, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sierra Oncology, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Wilmington, DE 19808 |
| Party Name | Sierra Oncology, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Vancouver, B.C. V6C3E8 CA |
| Event Date | Event Description |
| Wednesday, October 19, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, October 19, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, October 19, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, October 12, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, October 12, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, October 12, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 12, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, September 6, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, September 5, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, February 3, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, February 1, 2022 | SOU EXTENSION 1 GRANTED |
| Tuesday, February 1, 2022 | SOU EXTENSION 1 FILED |
| Tuesday, February 1, 2022 | TEAS EXTENSION RECEIVED |
| Tuesday, August 3, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 8, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 8, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 19, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, May 5, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, April 29, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 29, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 29, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 27, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 27, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, April 27, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, April 27, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, October 30, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 30, 2020 | NON-FINAL ACTION E-MAILED |
| Friday, October 30, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, October 30, 2020 | ASSIGNED TO EXAMINER |
| Friday, August 14, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, July 21, 2020 | NEW APPLICATION ENTERED IN TRAM |